The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease
Author
dc.contributor.author
Bevilacqua, Jorge
Author
dc.contributor.author
Guecaimburu Ehuletche, María del Rosario
Author
dc.contributor.author
Perna, Abayuba
Author
dc.contributor.author
Dubrovsky, Alberto
Author
dc.contributor.author
Franca, Marcondes C.
Author
dc.contributor.author
Vargas, Steven
Author
dc.contributor.author
Hegde, Madhuri
Author
dc.contributor.author
Claeys, Kristl G.
Author
dc.contributor.author
Straub, Volker
Author
dc.contributor.author
Daba, Nadia
Author
dc.contributor.author
Faria, Roberta
Author
dc.contributor.author
Periquet, Magali
Author
dc.contributor.author
Sparks, Susan
Author
dc.contributor.author
Thibault, Nathan
Author
dc.contributor.author
Araujo, Roberto
Admission date
dc.date.accessioned
2020-05-08T23:44:07Z
Available date
dc.date.available
2020-05-08T23:44:07Z
Publication date
dc.date.issued
2020
Cita de ítem
dc.identifier.citation
Orphanet Journal of Rare Diseases (2020) 15:11
es_ES
Identifier
dc.identifier.other
10.1186/s13023-019-1291-2
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/174633
Abstract
dc.description.abstract
Background Limb-girdle muscular dystrophy (LGMD) is a group of neuromuscular disorders of heterogeneous genetic etiology with more than 30 directly related genes. LGMD is characterized by progressive muscle weakness involving the shoulder and pelvic girdles. An important differential diagnosis among patients presenting with proximal muscle weakness (PMW) is late-onset Pompe disease (LOPD), a rare neuromuscular glycogen storage disorder, which often presents with early respiratory insufficiency in addition to PMW. Patients with PMW, with or without respiratory symptoms, were included in this study of Latin American patients to evaluate the profile of variants for the included genes related to LGMD recessive (R) and LOPD and the frequency of variants in each gene among this patient population. Results Over 20 institutions across Latin America (Brazil, Argentina, Peru, Ecuador, Mexico, and Chile) enrolled 2103 individuals during 2016 and 2017. Nine autosomal recessive LGMDs and Pompe disease were investigated in a 10-gene panel (ANO5, CAPN3, DYSF, FKRP, GAA, SGCA, SGCB, SGCD, SGCG, TCAP) based on reported disease frequency in Latin America. Sequencing was performed with Illumina's NextSeq500 and variants were classified according to ACMG guidelines; pathogenic and likely pathogenic were treated as one category (P) and variants of unknown significance (VUS) are described. Genetic variants were identified in 55.8% of patients, with 16% receiving a definitive molecular diagnosis; 39.8% had VUS. Nine patients were identified with Pompe disease. Conclusions The results demonstrate the effectiveness of this targeted genetic panel and the importance of including Pompe disease in the differential diagnosis for patients presenting with PMW.